ATE447400T1 - Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung - Google Patents

Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung

Info

Publication number
ATE447400T1
ATE447400T1 AT06789813T AT06789813T ATE447400T1 AT E447400 T1 ATE447400 T1 AT E447400T1 AT 06789813 T AT06789813 T AT 06789813T AT 06789813 T AT06789813 T AT 06789813T AT E447400 T1 ATE447400 T1 AT E447400T1
Authority
AT
Austria
Prior art keywords
aryl
combination
therapeutic use
heteroaryl compound
substituted bis
Prior art date
Application number
AT06789813T
Other languages
German (de)
English (en)
Inventor
Gary T Emmons
Sathapana Kongsamut
Craig N Karson
Corrine M Legoff
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE447400T1 publication Critical patent/ATE447400T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06789813T 2005-08-19 2006-08-16 Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung ATE447400T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70965505P 2005-08-19 2005-08-19
PCT/US2006/032027 WO2007024600A2 (en) 2005-08-19 2006-08-16 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof

Publications (1)

Publication Number Publication Date
ATE447400T1 true ATE447400T1 (de) 2009-11-15

Family

ID=37772166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06789813T ATE447400T1 (de) 2005-08-19 2006-08-16 Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung

Country Status (17)

Country Link
US (1) US7618650B2 (es)
EP (1) EP1928442B1 (es)
JP (1) JP2009504761A (es)
KR (1) KR20080038416A (es)
CN (1) CN101242819A (es)
AR (1) AR055609A1 (es)
AT (1) ATE447400T1 (es)
AU (1) AU2006283703A1 (es)
BR (1) BRPI0614943A2 (es)
CA (1) CA2617980A1 (es)
DE (1) DE602006010219D1 (es)
ES (1) ES2336142T3 (es)
MX (1) MX2008001778A (es)
RU (1) RU2008110498A (es)
SG (1) SG140147A1 (es)
TW (1) TW200815009A (es)
WO (1) WO2007024600A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
JP2012505892A (ja) 2008-10-15 2012-03-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｍｍｐ−１３阻害剤として有用な縮合ヘテロアリールジアミド化合物
CA2738929A1 (en) 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102018681A (zh) * 2010-12-10 2011-04-20 荣港生技医药科技（北京）有限公司 一种美乐托宁缓释剂、其制备方法及其应用
US20130060052A1 (en) * 2011-01-17 2013-03-07 Takeda Pharmaceutical Company Limited Orally dispersible tablet
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
BR112015022785A2 (pt) 2013-03-14 2017-07-18 Epizyme Inc composto; composição farmacêutica; kit ou artigo farmacêutico embalado; método de inibição de uma arginina metil transferase (rmt); método de modulação da expressão genética; método de modulação da transcrição; e método de tratamento de um distúrbio mediado por rmt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334868A (en) * 1996-10-21 2001-02-23 Neurosearch As 1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
AU5721301A (en) * 2000-04-24 2001-11-07 Teva Pharma Zolpidem hemitartrate
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a

Also Published As

Publication number Publication date
CA2617980A1 (en) 2007-03-01
TW200815009A (en) 2008-04-01
US20080138413A1 (en) 2008-06-12
ES2336142T3 (es) 2010-04-08
KR20080038416A (ko) 2008-05-06
WO2007024600A3 (en) 2007-05-24
CN101242819A (zh) 2008-08-13
MX2008001778A (es) 2008-04-07
DE602006010219D1 (de) 2009-12-17
EP1928442A2 (en) 2008-06-11
RU2008110498A (ru) 2009-09-27
AU2006283703A1 (en) 2007-03-01
AR055609A1 (es) 2007-08-29
JP2009504761A (ja) 2009-02-05
SG140147A1 (en) 2008-03-28
WO2007024600A2 (en) 2007-03-01
US7618650B2 (en) 2009-11-17
EP1928442B1 (en) 2009-11-04
BRPI0614943A2 (pt) 2011-04-26

Similar Documents

Publication Publication Date Title
ATE447400T1 (de) Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung
DE602006007831D1 (de) N-alkylcarbonylaminosäureester und n-alkylcarbonylaminosäurelaktonverbindungen und anwendung davon
LTPA2017026I1 (lt) Lakiųjų alkilinimo agentų stabilizuotos kompozicijos ir jų panaudojimo būdai
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
EP1845086A4 (en) N-SUBSTITUTED N-METHOXYCARBAMATES BY 2-SUBSTITUTED PHENYL GROUPS, THEIR SYNTHESIS AND THEIR APPLICATIONS
DE60306565D1 (de) Zusammensetzungen gegen Krebs zur topischen Anwendung
ATE543825T1 (de) Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel
DE602006019982D1 (de) Wässrige russdispersion und herstellungsverfahren dafür
DE602004004957D1 (de) Härtbare wässrige Zusammensetzung und ihre Verwendung als Vliesstoff-Bindemittel
ATE511509T1 (de) Azaindolylverbindungen und anwendungsverfahren
DE602006017183D1 (de) Benzimidazolderivat und anwendung davon
EP1970050A4 (en) INTRAVENOUS EMULSION OF BUTYLBENZENE PHTALEIN AND ITS APPLICATION
DE602006011336D1 (de) Wässrige russdispersion und herstellungsverfahren dafür
BRPI0614730A2 (pt) composto, composição farmacêutica, e, uso de um composto
IL184268A0 (en) N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid
BRPI0813017A2 (pt) " formulação líquida e uso de uma formulação líquida "
NO20080412L (no) Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
IL184158A0 (en) Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
FI20031190A0 (fi) Antioksidantti ja sen käyttö
DE112006003548A5 (de) Zubereitung und Anwendung eines Phytotherapeutikums
DE602006019130D1 (de) Filtervorrichtung und filterelement
NO20043937L (no) Anvendelse av vitamin D sammensetninger
BRPI0815124A2 (pt) Uso de um composto derivado de n-(2-tiazolil)-amida, composto, composição farmacêutica e cosmética contendo o mesmo
BRPI0617943A2 (pt) composto farmacêutico e uso de um composto farmacêutico
DE502004002797D1 (de) Ölfilteranordnung und filterelement

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties